Veeco’s niche leadership in annealing and ion-beam deposition offers exposure to AI-driven chipmaking growth, but margin pressure, export reviews, and merger uncertainty temper the five-year upside.
Overview
Veeco Instruments develops specialized capital equipment for semiconductor fabrication, compound semiconductors, data storage, and research, selling high-value systems alongside service, parts, maintenance, and upgrades. Its core platforms include LSA and NSA annealing, ion-beam deposition and etch, MOCVD, wet processing, packaging lithography, MBE, and ALD. Semiconductor equipment supplies roughly 65%–72% of revenue, while APAC represents over 50%–60% of quarterly billings. Veeco’s competitive position rests on leading LSA exposure, near-monopolistic IBD positioning for EUV mask blanks, process IP, and high switching costs. Q3 2026 revenue grew 26.2% year over year to $209.4 million but slightly missed consensus; non-GAAP EPS of $0.36 missed $0.45, and gross margin declined to 39.1% from 41.9%. FY2026 revenue guidance is $790–$820 million, and management expects standalone FY2027 revenue above $1.0 billion while more than doubling capacity in 2027. **The growth case is tied to AI-related logic, HBM packaging, and silicon photonics demand**, but margin recovery and manufacturing execution matter. At $37.19 on November 6, 2026, VECO traded at approximately 26.2x FY2026 midpoint non-GAAP EPS. The five-year probability-weighted target is $58.99; near-term catalysts include capacity ramp, margin normalization, and the pending Axcelis merger.